Skip to main content
Data show positive results for Lantheus' cardiac PET radiotracer

Lantheus Holdings' F-18 PET radiotracer LMI 1195 resulted in similar cardiac sympathetic innervation measurements and improved early cardiac imaging kinetics, compared with C-11 hydroxyephedrine, in a midstage trial. "We believe LMI 1195 may represent a first-in-class agent and useful diagnostic tool for a significant population of patients at risk for sudden cardiac death," said Dr. Cesare Orlandi of Lantheus Medical Imaging.

Full Story: